Japanese
close

FI (list display)

  • A61K38/00
    		•  Medicinal preparations containing peptides(peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergoline-based peptides A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) [6]
    		HB CC 4C084
  • A61K38/01
    		•  .Hydrolyzed proteins; Derivatives thereof [6] HB CC 4C084
  • A61K38/02
    		•  .Peptides of undefined number of amino acids; Derivatives thereof [6] HB CC 4C084
  • A61K38/03
    		•  .Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6] HB CC 4C084
  • A61K38/04
    		•  .Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (gastrins A61K38/16, somatostatins A61K38/31, melanotropins A61K38/34) [6] HB CC 4C084
  • A61K38/05
    		•  ..Dipeptides [6] HB CC 4C084
  • A61K38/06
    		•  ..Tripeptides [6] HB CC 4C084
  • A61K38/07
    		•  ..Tetrapeptides [6] HB CC 4C084
  • A61K38/08
    		•  ..Peptides having 5 to 11 amino acids [6] HB CC 4C084
  • A61K38/09
    		•  ...Luteinizing hormone-releasing hormone (LHRH); Related peptides [6] HB CC 4C084
  • A61K38/095
    		•  ...Oxytocins; Vasopressins; Related peptides HB CC 4C084
  • A61K38/10
    		•  ..Peptides having 12 to 20 amino acids [6] HB CC 4C084
  • A61K38/12
    		•  ..Cyclic peptides [6] HB CC 4C084
  • A61K38/13
    		•  ...Cyclosporins [6] HB CC 4C084
  • A61K38/14
    		•  ..Peptides containing saccharide radicals; Derivatives thereof [6] HB CC 4C084
  • A61K38/15
    		•  ..Depsipeptides; Derivatives thereof [6] HB CC 4C084
  • A61K38/16
    		•  .Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6] HB CC 4C084
  • A61K38/16,100
    		•  ..agglutinin HB CC 4C084
  • A61K38/16,200
    		•  ..proteinous enzyme inhibitors excluding protease inhibitors HB CC 4C084
  • A61K38/17
    		•  ..from animals; from humans [6] HB CC 4C084
  • A61K38/17,100
    		•  ...Globulins HB CC 4C084
  • A61K38/18
    		•  ...Growth factors; Growth regulators [6] HB CC 4C084
  • A61K38/19
    		•  ...Cytokines; Lymphokines; Interferons [6] HB CC 4C084
  • A61K38/20
    		•  ....Interleukins [6] HB CC 4C084
  • A61K38/21
    		•  ....Interferons [6] HB CC 4C084
  • A61K38/22
    		•  ...Hormones(derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K38/33, e.g. corticotropin A61K38/35) [6] HB CC 4C084
  • A61K38/23
    		•  ....Calcitonins [6] HB CC 4C084
  • A61K38/24
    		•  ....Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [6] HB CC 4C084
  • A61K38/25
    		•  ....Growth hormone-releasing factor [GH-RF], i.e. somatoliberin [2006.01] HB CC 4C084
  • A61K38/26
    		•  ....Glucagons [6] HB CC 4C084
  • A61K38/27
    		•  ....Growth hormone [GH], i.e. somatotropin [2006.01] HB CC 4C084
  • A61K38/28
    		•  ....Insulins [6] HB CC 4C084
  • A61K38/29
    		•  ....Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides [2006.01] HB CC 4C084
  • A61K38/30
    		•  ....Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 [2006.01] HB CC 4C084
  • A61K38/31
    		•  ....Somatostatins [6] HB CC 4C084
  • A61K38/32
    		•  ....Thymopoietins [6] HB CC 4C084
  • A61K38/33
    		•  ...derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [6] HB CC 4C084
  • A61K38/34
    		•  ....Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin [6] HB CC 4C084
  • A61K38/35
    		•  ....Corticotropin (ACTH) [6] HB CC 4C084
  • A61K38/36
    		•  ...Blood coagulation or fibrinolysis factors [6] HB CC 4C084
  • A61K38/37
    		•  ....Factors VIII [6] HB CC 4C084
  • A61K38/38
    		•  ...Albumins [6] HB CC 4C084
  • A61K38/39
    		•  ...Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [6] HB CC 4C084
  • A61K38/40
    		•  ...Transferrins, e.g. lactoferrins, ovotransferrins [6] HB CC 4C084
  • A61K38/41
    		•  ..Porphyrin- or corrin-ring-containing peptides [6] HB CC 4C084
  • A61K38/42
    		•  ...Haemoglobins; Myoglobins [6] HB CC 4C084
  • A61K38/43
    		•  ..Enzymes; Proenzymes; Derivatives thereof [6]
    		HB CC 4C084
  • A61K38/44
    		•  ...Oxidoreductases (1) [6] HB CC 4C084
  • A61K38/45
    		•  ...Transferases (2) [6] HB CC 4C084
  • A61K38/46
    		•  ...Hydrolases (3) [6] HB CC 4C084
  • A61K38/47
    		•  ....acting on glycosyl compounds (3.2), e.g. cellulases, lactases [6] HB CC 4C084
  • A61K38/48
    		•  ....acting on peptide bonds (3.4) [6] HB CC 4C084
  • A61K38/48,100
    		•  .....serine proteases, e.g. trypsin HB CC 4C084
  • A61K38/48,110
    		•  ......Kallikrein HB CC 4C084
  • A61K38/49
    		•  .....Urokinase; Tissue plasminogen activator [6] HB CC 4C084
  • A61K38/50
    		•  ....acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase [6] HB CC 4C084
  • A61K38/51
    		•  ...Lyases (4) [6] HB CC 4C084
  • A61K38/52
    		•  ...Isomerases (5) [6] HB CC 4C084
  • A61K38/53
    		•  ...Ligases (6) [6] HB CC 4C084
  • A61K38/54
    		•  ...Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 to A61K38/46 or A61K38/51 to A61K38/53 [6] HB CC 4C084
  • A61K38/55
    		•  ..Protease inhibitors [6] HB CC 4C084
  • A61K38/56
    		•  ...from plants [6] HB CC 4C084
  • A61K38/57
    		•  ...from animals; from humans [6] HB CC 4C084
  • A61K38/58
    		•  ....from leeches, e.g. hirudin, eglin [6] HB CC 4C084
    TOP